UnitedHealth Group Incorporated $UNH Holdings Raised by Ewa LLC

Ewa LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,045 shares of the healthcare conglomerate’s stock after purchasing an additional 81 shares during the quarter. Ewa LLC’s holdings in UnitedHealth Group were worth $326,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Naples Global Advisors LLC raised its position in UnitedHealth Group by 9.8% in the second quarter. Naples Global Advisors LLC now owns 16,830 shares of the healthcare conglomerate’s stock worth $5,251,000 after acquiring an additional 1,505 shares in the last quarter. Pure Financial Advisors LLC increased its stake in UnitedHealth Group by 228.6% in the 2nd quarter. Pure Financial Advisors LLC now owns 15,876 shares of the healthcare conglomerate’s stock worth $4,953,000 after purchasing an additional 11,045 shares in the last quarter. Woodward Diversified Capital LLC increased its stake in UnitedHealth Group by 44.9% in the 2nd quarter. Woodward Diversified Capital LLC now owns 1,304 shares of the healthcare conglomerate’s stock worth $407,000 after purchasing an additional 404 shares in the last quarter. New Wave Wealth Advisors LLC purchased a new position in UnitedHealth Group during the 2nd quarter valued at about $229,000. Finally, BloombergSen Inc. purchased a new position in UnitedHealth Group during the 2nd quarter valued at about $23,619,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 0.7%

UNH opened at $347.82 on Thursday. The business has a 50 day moving average of $304.76 and a 200-day moving average of $357.57. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $315.01 billion, a price-to-earnings ratio of 15.07, a P/E/G ratio of 2.25 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on UNH. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Piper Sandler lowered their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Truist Financial boosted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Finally, Sanford C. Bernstein boosted their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.